This unit covers the epidemiology and etiology of fibroids, signs and symptoms in patients, diagnosis, treatment, and surgical options for patients. At the conclusion of the presentation, participants will review two complicated cases and should be able to list the epidemiologic risk factors and known mechanisms of uterine fibroid development. They will also be able to list the indications, benefits and risks, efficacy, and side effects of medical therapy, surgical intervention, and uterine artery embolization for symptomatic leiomyomata. After exploring the role of new technologies in the treatment of uterine leiomyomata, clinicians should be able to select fertility-preserving treatments for uterine fibroids in women desiring fertility.
Physicians can purchase the eModule, access it at the link below, and receive CME credit once they achieve 80% or higher on the posttest.
The American College of Obstetricians and Gynecologists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)™
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
College Cognate Credit(s)
The American College of Obstetricians and Gynecologists designates this enduring material for a maximum of 7 Category 1 College Cognate Credits. The College has a reciprocity agreement with the AMA that allows AMA PRA Category 1 Credits™ to be equivalent to College Cognate Credits.
Conflict of Interest Disclosure
The ACOG eModule Leiomyoma was developed under the direction of the eModule Advisory Committee and contributor. The ACOG eModule is planned and produced in accordance with the Standards for Enduring Materials of the Accreditation Council for Continuing Medical Education. Any discussion of unapproved use of products is clearly cited in the appropriate critique.
Current guidelines state that continuing medical education (CME) providers must ensure that CME activities are free from the control of any commercial interest. The contributor(s) and the advisory council declare that neither they nor any business associate nor any member of their immediate families has material interest, financial interest, or other relationships with any company manufacturing commercial products relative to the topics included in this publication or with any provider of commercial services discussed in the eModule.
Credit for each ACOG eModule will be available for 3 years from the initial date of release or revision.